Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionalpha-glucosidase activity

GANAB SI GAA

1.09e-067643GO:0090599
GeneOntologyMolecularFunctionglucosidase activity

GANAB SI GAA

1.39e-0515643GO:0015926
GeneOntologyMolecularFunctionalpha-1,4-glucosidase activity

SI GAA

1.01e-045642GO:0004558
GeneOntologyMolecularFunctionhydrolase activity, hydrolyzing O-glycosyl compounds

GANAB GLB1 SI GAA

3.34e-04103644GO:0004553
GeneOntologyMolecularFunctionpotassium:chloride symporter activity

SLC12A4 SLC12A7

3.59e-049642GO:0015379
GeneOntologyMolecularFunctionammonium channel activity

SLC12A4 SLC12A7

6.54e-0412642GO:0008519
GeneOntologyMolecularFunctionhydrolase activity, acting on glycosyl bonds

GANAB GLB1 SI GAA

1.18e-03144644GO:0016798
GeneOntologyMolecularFunctionchloride:monoatomic cation symporter activity

SLC12A4 SLC12A7

2.45e-0323642GO:0015377
GeneOntologyMolecularFunctionmonoatomic anion:monoatomic cation symporter activity

SLC12A4 SLC12A7

3.13e-0326642GO:0015296
GeneOntologyMolecularFunctioncarbohydrate binding

GANAB MRC2 SI FREM1 GAA

3.15e-03310645GO:0030246
DomainGlyco_hydro_31_CS

GANAB SI GAA

1.53e-074643IPR030459
DomainGLYCOSYL_HYDROL_F31_2

GANAB SI GAA

3.82e-075643PS00707
DomainGlyco_hydro_31_AS

GANAB SI GAA

7.62e-076643IPR030458
DomainGlyco_hydro_31

GANAB SI GAA

1.33e-067643IPR000322
DomainGlyco_hydro_31

GANAB SI GAA

1.33e-067643PF01055
DomainGLYCOSYL_HYDROL_F31_1

GANAB SI GAA

1.33e-067643PS00129
DomainGal_mutarotase_SF_dom

GANAB SI GAA

2.52e-0517643IPR011013
DomainGlycoside_hydrolase_SF

GANAB GLB1 SI GAA

3.24e-0553644IPR017853
DomainGlyco_hydro_31_N_dom

GANAB GAA

3.46e-053642IPR025887
DomainGal_mutarotas_2

GANAB GAA

3.46e-053642PF13802
DomainWD_REPEATS_1

EML6 NUP43 FBXW2 EIF3B IFT80 SPAG16 EML3

4.52e-05278647PS00678
DomainWD_REPEATS_2

EML6 NUP43 FBXW2 EIF3B IFT80 SPAG16 EML3

4.62e-05279647PS50082
DomainWD_REPEATS_REGION

EML6 NUP43 FBXW2 EIF3B IFT80 SPAG16 EML3

4.62e-05279647PS50294
DomainNtCtMGAM_N

SI GAA

6.90e-054642PF16863
DomainGal_mutarotase_N

SI GAA

6.90e-054642IPR031727
DomainKCL_cotranspt

SLC12A4 SLC12A7

6.90e-054642IPR000076
Domain-

GLB1 LAMC3 SSPOP NRP1

1.14e-04736442.60.120.260
Domain-

EML6 NUP43 FBXW2 EIF3B IFT80 SPAG16 EML3

1.40e-043336472.130.10.10
DomainWD40/YVTN_repeat-like_dom

EML6 NUP43 FBXW2 EIF3B IFT80 SPAG16 EML3

1.45e-04335647IPR015943
DomainHELP

EML6 EML3

1.72e-046642PF03451
DomainHELP

EML6 EML3

1.72e-046642IPR005108
DomainSLC12A_fam

SLC12A4 SLC12A7

2.40e-047642IPR004842
DomainVWFC_1

PXDNL KCP SSPOP

2.53e-0436643PS01208
DomainWD40

EML6 NUP43 FBXW2 IFT80 SPAG16 EML3

2.57e-04259646PF00400
DomainVWC

PXDNL KCP SSPOP

2.97e-0438643SM00214
DomainVWFC_2

PXDNL KCP SSPOP

2.97e-0438643PS50184
DomainGalactose-bd-like

GLB1 LAMC3 SSPOP NRP1

3.03e-0494644IPR008979
DomainWD40

EML6 NUP43 FBXW2 IFT80 SPAG16 EML3

3.08e-04268646SM00320
DomainSLC12_C

SLC12A4 SLC12A7

3.19e-048642IPR018491
DomainTrefoil

SI GAA

3.19e-048642PF00088
DomainSLC12

SLC12A4 SLC12A7

3.19e-048642PF03522
DomainP_TREFOIL_1

SI GAA

3.19e-048642PS00025
DomainP_trefoil_CS

SI GAA

3.19e-048642IPR017957
DomainWD40_repeat

EML6 NUP43 FBXW2 IFT80 SPAG16 EML3

3.34e-04272646IPR001680
DomainVWF_dom

PXDNL KCP SSPOP

4.00e-0442643IPR001007
DomainP_TREFOIL_2

SI GAA

4.10e-049642PS51448
DomainPD

SI GAA

4.10e-049642SM00018
DomainWD40_repeat_dom

EML6 NUP43 FBXW2 IFT80 SPAG16 EML3

5.32e-04297646IPR017986
Domain-

SI GAA

6.23e-04116424.10.110.10
DomainP_trefoil_dom

SI GAA

7.46e-0412642IPR000519
DomainQuinoprotein_ADH-like_supfam

EML6 FBXW2 EML3

7.96e-0453643IPR011047
DomainUnchr_dom_Cys-rich

KCP SSPOP

8.80e-0413642IPR014853
DomainC8

KCP SSPOP

8.80e-0413642SM00832
DomainTIL_dom

KCP SSPOP

1.02e-0314642IPR002919
DomainVWD

KCP SSPOP

1.34e-0316642SM00216
DomainVWF_type-D

KCP SSPOP

1.34e-0316642IPR001846
DomainVWFD

KCP SSPOP

1.34e-0316642PS51233
DomainVWD

KCP SSPOP

1.34e-0316642PF00094
DomainVWC_out

KCP SSPOP

1.90e-0319642SM00215
DomainFA58C

SSPOP NRP1

2.33e-0321642SM00231
DomainFA58C_3

SSPOP NRP1

2.33e-0321642PS50022
DomainFA58C_1

SSPOP NRP1

2.33e-0321642PS01285
DomainFA58C_2

SSPOP NRP1

2.33e-0321642PS01286
DomainWD40_repeat_CS

EML6 NUP43 FBXW2 SPAG16

2.42e-03164644IPR019775
DomainAA-permease/SLC12A_dom

SLC12A4 SLC12A7

2.55e-0322642IPR004841
DomainAA_permease

SLC12A4 SLC12A7

2.55e-0322642PF00324
DomainF5_F8_type_C

SSPOP NRP1

3.04e-0324642PF00754
DomainFA58C

SSPOP NRP1

3.04e-0324642IPR000421
Domain-

CD1E ULBP3

3.04e-03246423.30.500.10
DomainMHC_I-like_Ag-recog

CD1E ULBP3

3.04e-0324642IPR011161
DomainVWC

PXDNL KCP

4.13e-0328642PF00093
DomainConA-like_dom

SVEP1 RYR3 TRIM7 NRP1

6.75e-03219644IPR013320
PathwayREACTOME_DISEASES_OF_CARBOHYDRATE_METABOLISM

GLB1 SI IDS GAA

4.67e-0634474M27546
PathwayREACTOME_DISEASES_OF_METABOLISM

GLB1 SI THSD7B IDS SSPOP GAA

1.71e-04250476M27554
PathwayREACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS

SLC12A4 SLC12A7

2.26e-047472M27339
PathwayREACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS

SLC12A4 SLC12A7

2.26e-047472MM15081
Pubmed

Temporal neuropathologic and behavioral phenotype of 6neo/6neo Pompe disease mice.

GANAB GAA

3.44e-06265218648322
Pubmed

RNA binding protein PUM2 promotes the stemness of breast cancer cells via competitively binding to neuropilin-1 (NRP-1) mRNA with miR-376a.

PUM2 NRP1

3.44e-06265230909144
Pubmed

p90 activation contributes to cerebral ischemic damage via phosphorylation of Na+/H+ exchanger isoform 1.

SLC9A1 RPS6KA1

3.44e-06265220557427
Pubmed

Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.

PUM2 IFT80 THSD7B CADPS2 SSPOP

4.66e-0613065512421765
Pubmed

Na+/H+ exchanger isoform 1-induced osteopontin expression facilitates cardiac hypertrophy through p90 ribosomal S6 kinase.

SLC9A1 RPS6KA1

1.03e-05365229473817
Pubmed

A dominant negative mutant of the KCC1 K-Cl cotransporter: both N- and C-terminal cytoplasmic domains are required for K-Cl cotransport activity.

SLC12A4 SLC12A7

1.03e-05365211551954
Pubmed

Insulin-like growth factor 1 stimulates KCl cotransport, which is necessary for invasion and proliferation of cervical cancer and ovarian cancer cells.

SLC12A4 SLC12A7

1.03e-05365215262997
Pubmed

K-Cl cotransporter gene expression during human and murine erythroid differentiation.

SLC12A4 SLC12A7

1.03e-05365221733850
Pubmed

Proteomic identification of common SCF ubiquitin ligase FBXO6-interacting glycoproteins in three kinds of cells.

GANAB GLB1 MRC2 FBXW2 C1RL EIF3B ECE1 GAA

1.86e-0561365822268729
Pubmed

ERK1/2-p90RSK-mediated phosphorylation of Na+/H+ exchanger isoform 1. A role in ischemic neuronal death.

SLC9A1 RPS6KA1

2.06e-05465217664275
Pubmed

Influence of K-Cl cotransporter activity on activation of volume-sensitive Cl- channels in human osteoblasts.

SLC12A4 SLC12A7

2.06e-05465212637262
Pubmed

Inhibition of human immunodeficiency virus syncytium formation and virus replication by castanospermine.

GANAB GAA

2.06e-0546522825177
Pubmed

Ece1 and Tbx1 define distinct pathways to aortic arch morphogenesis.

ECE1 NRP1

2.06e-05465212950083
Pubmed

Effects of the imino sugar N-butyldeoxynojirimycin on the N-glycosylation of recombinant gp120.

GANAB GAA

2.06e-0546528416962
Pubmed

Effect of a glucosidase inhibitor on the bioactivity and immunoreactivity of human immunodeficiency virus type 1 envelope glycoprotein.

GANAB GAA

3.43e-0556521678778
Pubmed

N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with changes in antibody recognition of the V1/V2 region of gp120.

GANAB GAA

3.43e-0556528794361
Pubmed

N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with impaired gp120 shedding and gp41 exposure.

GANAB GAA

3.43e-0556528794362
Pubmed

The alpha-glucosidase inhibitor 1-deoxynojirimycin blocks human immunodeficiency virus envelope glycoprotein-mediated membrane fusion at the CXCR4 binding step.

GANAB GAA

3.43e-05565211752220
Pubmed

N-Glycans in the gp120 V1/V2 domain of the HIV-1 strain NL4-3 are indispensable for viral infectivity and resistance against antibody neutralization.

GANAB GAA

5.13e-05665216547752
Pubmed

Inhibition of HIV and SIV infectivity by blockade of alpha-glucosidase activity.

GANAB GAA

5.13e-0566521704656
Pubmed

Hyperglycosylated mutants of human immunodeficiency virus (HIV) type 1 monomeric gp120 as novel antigens for HIV vaccine design.

GANAB GAA

5.13e-05665212719582
Pubmed

Interference with HIV-induced syncytium formation and viral infectivity by inhibitors of trimming glucosidase.

GANAB GAA

5.13e-0566522959866
Pubmed

Temporal expression of HIV-1 envelope proteins in baculovirus-infected insect cells: implications for glycosylation and CD4 binding.

GANAB GAA

7.18e-0576522076345
Pubmed

AIDS and glycosylation.

GANAB GAA

7.18e-0576522136376
Pubmed

Similar effects of all WNK3 variants on SLC12 cotransporters.

SLC12A4 SLC12A7

9.56e-05865221613606
Pubmed

Disruption of KCC2 reveals an essential role of K-Cl cotransport already in early synaptic inhibition.

SLC12A4 SLC12A7

9.56e-05865211395011
Pubmed

The WNK-regulated SPAK/OSR1 kinases directly phosphorylate and inhibit the K+-Cl- co-transporters.

SLC12A4 SLC12A7

9.56e-05865224393035
Pubmed

Cation chloride cotransporters interact with the stress-related kinases Ste20-related proline-alanine-rich kinase (SPAK) and oxidative stress response 1 (OSR1).

SLC12A4 SLC12A7

9.56e-05865212386165
Pubmed

Cation-chloride cotransporters and neuronal function.

SLC12A4 SLC12A7

1.23e-04965219323993
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

SETD1A SLC12A4 SZT2 CSAD LAMC3 ECE1 EML3 RAI1 TRIM7

2.07e-04110565935748872
Pubmed

Venous endothelin modulates responsiveness of cardiac sympathetic axons to arterial semaphorin.

ECE1 NRP1

3.08e-041465230735130
Pubmed

Local anesthetics impair the growth and self-renewal of glioblastoma stem cells by inhibiting ZDHHC15-mediated GP130 palmitoylation.

DPYS GANAB SSPOP

3.25e-047165333541421
Pubmed

FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.

LOXHD1 EXPH5 ARID2 HPX RAI1 RYR3

3.35e-0449765636774506
Pubmed

Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells.

GANAB GAA

4.59e-04176522355006
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

ARHGAP4 SETD1A SZT2 MRC2 IFT80 RAI1

4.65e-0452965614621295
Pubmed

Prediction of the coding sequences of unidentified human genes. VI. The coding sequences of 80 new genes (KIAA0201-KIAA0280) deduced by analysis of cDNA clones from cell line KG-1 and brain.

MYO18A PUM2 BCL2L2

5.14e-04836539039502
Pubmed

Large-scale proteomics and phosphoproteomics of urinary exosomes.

DPYS GANAB GLB1 UPK1A HPX ECE1 SHROOM2 GAA

5.97e-04101665819056867
Pubmed

High-throughput analyses of hnRNP H1 dissects its multi-functional aspect.

GANAB SLC12A4 SZT2 PUM2 FBXW2 C1RL BCL2L2 NSUN2

6.16e-04102165826760575
Pubmed

Glycosylation inhibitors and neuraminidase enhance human immunodeficiency virus type 1 binding and neutralization by mannose-binding lectin.

GANAB GAA

6.39e-042065212560567
Pubmed

Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease.

ZBP1 ARID2

6.39e-042065219668339
Pubmed

The transcriptional repressor Blimp1/Prdm1 regulates postnatal reprogramming of intestinal enterocytes.

GLB1 SI

7.06e-042165221670299
Pubmed

Influence of N-linked glycans in V4-V5 region of human immunodeficiency virus type 1 glycoprotein gp160 on induction of a virus-neutralizing humoral response.

GANAB GAA

7.76e-04226528673525
Pubmed

Effect of various glycosidase treatments on the resistance of the HIV-1 envelope to degradation.

GANAB GAA

7.76e-04226529109416
Pubmed

Rare independent mutations in renal salt handling genes contribute to blood pressure variation.

SLC12A4 SLC12A7

7.76e-042265218391953
Pubmed

Folding of the human immunodeficiency virus type 1 envelope glycoprotein in the endoplasmic reticulum.

GANAB GAA

7.76e-042265211530211
Pubmed

Role of asparagine-linked glycosylation in human immunodeficiency virus type 1 transmembrane envelope function.

GANAB GAA

8.48e-04236521736542
Pubmed

Functional role of the glycan cluster of the human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) ectodomain.

GANAB GAA

8.48e-04236528093218
Pubmed

Glycosylation inhibitors block the expression of LAV/HTLV-III (HIV) glycoproteins.

GANAB GAA

8.48e-04236523099781
Pubmed

Role of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1.

GANAB GAA

8.48e-04236523264072
Pubmed

Effect of N-(3-phenyl-2-propenyl)-1-deoxynojirimycin on the lectin binding to HIV-1 glycoproteins.

GANAB GAA

1.00e-03256522283726
Pubmed

Site-specific N-glycosylation and oligosaccharide structures of recombinant HIV-1 gp120 derived from a baculovirus expression system.

GANAB GAA

1.09e-03266528218172
Pubmed

Mice carrying a hypomorphic Evi1 allele are embryonic viable but exhibit severe congenital heart defects.

ECE1 NRP1

1.17e-032765224586749
Pubmed

Intestinal NCoR1, a regulator of epithelial cell maturation, controls neonatal hyperbilirubinemia.

GLB1 SI

1.17e-032765228167773
Pubmed

Identification of Arx transcriptional targets in the developing basal forebrain.

CADPS2 SHROOM2

1.26e-032865218799476
Pubmed

Spatiotemporal Analysis of a Glycolytic Activity Gradient Linked to Mouse Embryo Mesoderm Development.

GLB1 ACSS2 GAA

1.29e-0311465328245920
Pubmed

Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.

GLB1 RPS6KA1 ECE1 SLC12A7 NSUN2 NRP1

1.35e-0365065638777146
Pubmed

Systematic analysis of human protein complexes identifies chromosome segregation proteins.

GANAB ARID2 NUP43 GPATCH4 EIF3B NSUN2 EML3 PPP1R12C

1.36e-03115565820360068
Pubmed

Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.

TNN HPX GAA NRP1

1.38e-0325765416335952
Pubmed

Global landscape of HIV-human protein complexes.

GANAB PUM2 GPATCH4 EIF3B EML3

1.66e-0345765522190034
Pubmed

Integral and associated lysosomal membrane proteins.

SLC12A4 ECE1 GAA

1.72e-0312665317897319
Pubmed

LZTR1 is a regulator of RAS ubiquitination and signaling.

SLC12A4 RPS6KA1 SLC12A7

1.76e-0312765330442766
Pubmed

Rewiring of RSK-PDZ Interactome by Linear Motif Phosphorylation.

RPS6KA1 SHROOM2

1.86e-033465230726710
Cytoband11q12.3

GANAB EML3

1.34e-033865211q12.3
GeneFamilyWD repeat domain containing

EML6 NUP43 FBXW2 IFT80 SPAG16 EML3

3.89e-05262446362
GeneFamilyArmadillo repeat containing|Protein phosphatase 1 regulatory subunits

TMEM132C SLC9A1 BCL2L2 PPP1R12C

9.65e-04181444694
CoexpressionNABA_ECM_GLYCOPROTEINS

PXDNL TNN KCP LAMC3 SSPOP SVEP1

8.47e-06196646M3008
CoexpressionGSE7460_WT_VS_FOXP3_HET_ACT_TCONV_UP

IFT80 ACSS2 ECE1 SLC12A7 EML3 NRP1

9.23e-06199646M5709
CoexpressionMILI_PSEUDOPODIA_HAPTOTAXIS_DN

SETD1A SLC9A1 GANAB SLC12A4 GLB1 MRC2 ECE1 GAA RAI1

3.94e-05681649M5314
CoexpressionLI_ESTROGENE_LATE_E2_RESPONSE_DN

UPK1A HPX CA5B SSPOP

4.45e-0580644M48218
CoexpressionSENGUPTA_EBNA1_ANTICORRELATED

ARHGAP4 RPS6KA1 HPX IDS EML3

4.68e-05161645M18742
CoexpressionMILI_PSEUDOPODIA_HAPTOTAXIS_DN

SETD1A SLC9A1 GANAB SLC12A4 GLB1 MRC2 ECE1 GAA RAI1

5.03e-05703649MM1055
CoexpressionNABA_CORE_MATRISOME

PXDNL TNN KCP LAMC3 SSPOP SVEP1

5.69e-05275646M5884
CoexpressionMOTAMED_RESPONSE_TO_ANDROGEN_UP

IDS SSPOP

8.75e-056642M1148
CoexpressionNABA_ECM_GLYCOPROTEINS

TNN KCP LAMC3 SSPOP SVEP1

1.05e-04191645MM17059
CoexpressionGSE29949_CD8_NEG_DC_SPLEEN_VS_DC_BRAIN_UP

SLC12A4 UPK1A SZT2 TNN SHROOM2

1.10e-04193645M8394
CoexpressionGSE3982_BCELL_VS_BASOPHIL_UP

ZBP1 SZT2 EIF3B GAA PSD4

1.27e-04199645M5538
CoexpressionMANNO_MIDBRAIN_NEUROTYPES_HPERIC

SLC9A1 MRC2 TNN KCP LAMC3 ECE1 SLC12A7 EML3 SVEP1

1.28e-04795649M39050
CoexpressionGSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY8_EFFECTOR_CD8_TCELL_DN

SLC12A4 ARID2 ECE1 EML3 RAI1

1.30e-04200645M9479
CoexpressionGSE22886_CTRL_VS_LPS_24H_DC_UP

ARHGAP4 FBXW2 MRPL3 EIF3B NRP1

1.30e-04200645M4518
CoexpressionGSE21670_UNTREATED_VS_TGFB_IL6_TREATED_STAT3_KO_CD4_TCELL_DN

ARHGAP4 IFT80 ACSS2 SLC12A7 PSD4

1.30e-04200645M7444
ToppCellLPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type

TMEM132C PXDNL MRC2 SVEP1 FREM1 NRP1

4.75e-07200656a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW16-Neuroepithelial-Proteoglycan-expressing_cell|GW16 / Sample Type, Dataset, Time_group, and Cell type.

SLC12A4 MRC2 RPS6KA1 LAMC3 BCL2L2 SLC12A7

4.75e-07200656da45a85a4667965b24ba824af871157af5b4cd19
ToppCellTracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

TMEM132C MRC2 TNN LAMC3 FREM1 NRP1

4.75e-072006568ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW16-Neuroepithelial|GW16 / Sample Type, Dataset, Time_group, and Cell type.

SLC12A4 MRC2 RPS6KA1 LAMC3 BCL2L2 SLC12A7

4.75e-0720065625f4c051c2e869481f33c22ad54de97efac444ad
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

EXPH5 LAMC3 SLC12A7 SVEP1 RYR3

5.75e-061756559d09636a103daa8f622c3dbfd1f1536aaec3b6bb
ToppCellLPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TMEM132C PXDNL SVEP1 FREM1 NRP1

6.08e-06177655b7fee75de7e96924af488a5baa2334711889ae7c
ToppCellChildren_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

TMEM132C DPYS SVEP1 FREM1 NRP1

6.77e-061816559ede19228ba5c0668a9c06c915510b95585216ef
ToppCellLPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TMEM132C PXDNL MRC2 SVEP1 FREM1

8.35e-06189655a153b83314cf52808f685296cff8c95af3f4983d
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

LOXHD1 MRC2 LAMC3 SVEP1 NRP1

8.57e-061906551f83f7f24288a3b9ab33c2e113e845dba96adc8a
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

LOXHD1 MRC2 LAMC3 SVEP1 NRP1

8.57e-061906552306aa9dbeaef3be8484a5b236605de23cd75d4c
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

LOXHD1 MRC2 LAMC3 SVEP1 NRP1

8.79e-06191655a58c75e9580139fb370b498d95660f10f3a2a27b
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TMEM132C PXDNL MRC2 SVEP1 FREM1

8.79e-06191655b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

LOXHD1 MRC2 LAMC3 SVEP1 NRP1

9.01e-061926559093a9e94a25682d109a7f6edc256a25a61103a0
ToppCellLPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TMEM132C PXDNL MRC2 SVEP1 FREM1

9.01e-06192655dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TMEM132C PXDNL MRC2 SVEP1 FREM1

9.01e-061926556f4ef24dab544681304b7f8a9dc073e7edaa4cf5
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TMEM132C PXDNL MRC2 SVEP1 FREM1

9.01e-061926553d0cb19f037f604253d7d728689aeaa94251e92b
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

LOXHD1 MRC2 LAMC3 SVEP1 NRP1

9.01e-061926559ed5d49621ec1aa01716dc369bba1450b5f015f5
ToppCellLPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TMEM132C PXDNL MRC2 SVEP1 FREM1

9.01e-06192655deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TMEM132C PXDNL MRC2 SVEP1 FREM1

9.24e-06193655fb28717fadd06c3840636d25409ce80c9254bd34
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

LOXHD1 MRC2 LAMC3 SVEP1 NRP1

9.24e-06193655f1199518c3626fd29bfce65070dd21a660671213
ToppCellMesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor

TMEM132C MRC2 SVEP1 FREM1 NRP1

9.24e-06193655acad568621ed677031797b8c2e34dafea798d681
ToppCellLPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TMEM132C PXDNL MRC2 SVEP1 FREM1

9.48e-0619465560622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCellFetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

TMEM132C MRC2 SVEP1 FREM1 NRP1

9.48e-06194655011e14d9ed1393275f892060e7708ffadcd0767f
ToppCellLPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TMEM132C PXDNL MRC2 SVEP1 FREM1

9.48e-061946556e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCellLPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TMEM132C PXDNL MRC2 SVEP1 FREM1

9.48e-0619465589b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

LOXHD1 MRC2 LAMC3 SVEP1 FREM1

9.96e-06196655a12dd986df65c36f248cf10815c3b8b6238613b0
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

LOXHD1 MRC2 LAMC3 SVEP1 FREM1

9.96e-061966553e6803587d8566fd08cb8b290be3b6461743d79c
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

LOXHD1 MRC2 LAMC3 SVEP1 FREM1

1.02e-05197655b349f8e96d61a4c296af64711e11fc44459a9413
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

LOXHD1 MRC2 LAMC3 SVEP1 FREM1

1.02e-051976556d027119a5f7ca2aac1b10837e43f9a2bb54db85
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

LOXHD1 MRC2 LAMC3 SVEP1 FREM1

1.02e-05197655c2e390653d5dee7e731c1840cfdab41987dede9b
ToppCellFetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

TMEM132C MRC2 SVEP1 FREM1 NRP1

1.05e-0519865521cf4d81386761d09d0f6829c01c198e5524176d
ToppCellLPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

TMEM132C PXDNL MRC2 SVEP1 FREM1

1.07e-0519965530d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCellControl_saline-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type

TMEM132C PXDNL MRC2 SVEP1 FREM1

1.07e-05199655c2c42ecf20d1924edc2f899c01dfa5fcf3c210b9
ToppCellTracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

TMEM132C MRC2 SVEP1 FREM1 NRP1

1.10e-05200655b4ccffdd79526c85e5273d27b668dbddcddba1ee
ToppCellLPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

TMEM132C PXDNL MRC2 SVEP1 FREM1

1.10e-052006559b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCellTracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

TMEM132C MRC2 SVEP1 FREM1 NRP1

1.10e-052006553dd022e974fec7013ba18f333da63f58fbf2dd7c
ToppCellControl_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type

TMEM132C PXDNL MRC2 SVEP1 FREM1

1.10e-0520065564ae5cf6cb4fc94cf1052abd82648f6b8e6445fe
ToppCellLPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

TMEM132C PXDNL MRC2 SVEP1 FREM1

1.10e-05200655b79628fd1386aa9a3b0e9fa81def0bc100c3c073
ToppCellLPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

TMEM132C PXDNL MRC2 SVEP1 FREM1

1.10e-0520065550ca6550998e461ef26dd670351060bd940765a8
ToppCellControl_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type

TMEM132C PXDNL MRC2 SVEP1 FREM1

1.10e-05200655a1fc74c1b27e104895910bc7cdce7ba33d30df7e
ToppCellControl_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type

TMEM132C PXDNL MRC2 SVEP1 FREM1

1.10e-05200655bd8cf33502adea320e91ca2af14e1911d88ad374
ToppCellTracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

TMEM132C MRC2 SVEP1 FREM1 NRP1

1.10e-0520065558b38f9a484ee94191091a0659ed62ebed2d4a14
ToppCellCOVID-19-kidney-Mito-rich_Int|kidney / Disease (COVID-19 only), tissue and cell type

CD1E LAMC3 THSD7B SVEP1

3.81e-0512965457b705106aec7bbfc587de1ccd4f2335fc44dd6f
ToppCellprimary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Col8a1_Rprm|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

THSD7B RYR3 NRP1 PSD4

4.17e-0513265466ec5a06eece27c0aafb548f51db9fee595e71bc
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

LOXHD1 EML6 CADPS2 FREM1

6.18e-05146654e887e9de895fd453faa703997ef372cc6410fc49
ToppCellprimary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Krt80_Sla|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

SLC12A4 THSD7B RYR3 NRP1

7.04e-05151654f50c5ae9dae507df750df25e151b58685fec70ce
ToppCellfacs-Liver|facs / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DPYS HPX ASPDH NRP1

8.39e-05158654ea7db6bd9742153ceb6e444892a6d1df9c7fcc96
ToppCelltumor_Lymph_Node_/_Brain-Myeloid_cells-CD1c+_DCs|Myeloid_cells / Location, Cell class and cell subclass

CD1E LOXHD1 EXPH5 RYR3

8.60e-05159654b3c52908cd24bbf851fac69db3850fc7f53c2092
ToppCellfacs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KCP SVEP1 FREM1 RYR3

8.81e-05160654c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCellfacs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KCP SVEP1 FREM1 RYR3

8.81e-0516065425c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCellwk_08-11-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

CSAD THSD7B CPT1B RYR3

9.46e-051636541e8730d75cccf7292010683ab4e81a69d8e3bfa9
ToppCell3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LAMC3 SHROOM2 FREM1 RYR3

9.69e-05164654d167c7a987b9b35d1e7725c803df4f9cd5380e47
ToppCellprimary_visual_cortex-Non-neuronal-leptomeningeal_cell|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

ZBP1 MRC2 LAMC3 SVEP1

1.22e-041746542891ab2fd05eb4bbd239d1a2865f21ef7f2df39e
ToppCellprimary_visual_cortex-Non-neuronal-leptomeningeal_cell-VLMC|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

ZBP1 MRC2 LAMC3 SVEP1

1.22e-04174654eade55f86ef1f7a5355ad65cec3aa6bfc5d3c62d
ToppCellRV-11._Adipocyte|World / Chamber and Cluster_Paper

TMEM132C CSAD ACSS2 SVEP1

1.30e-04177654f0edf04930692418953e4f00a917257804ec0ffd
ToppCellPrimary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

RTP5 THSD7B SLC12A7 SVEP1

1.33e-041786543c973aac16988e88f5677d3d695dd772ccfd6570
ToppCellRV-11._Adipocyte|RV / Chamber and Cluster_Paper

TMEM132C CSAD ACSS2 SVEP1

1.33e-04178654278bbea5cf8f0589f71675c7a3d00679391b5253
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

EXPH5 SLC12A7 SVEP1 RYR3

1.33e-041786542a36475c260088f69f3b8c282d910e5eaa5c5c2d
ToppCell368C-Myeloid-Macrophage-SPP1+_Macrophage_3|368C / Donor, Lineage, Cell class and subclass (all cells)

RPS6KA1 KCP TRIM7 PSD4

1.33e-04178654536a601abcc60867949ea06e9aafb6c7b799b56b
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

MRC2 LAMC3 SVEP1 NRP1

1.33e-0417865478a0c6340001a77f5b2d890b6263f574af2e72da
ToppCell356C-Lymphocytic-CD4_T-cell-Treg_cell_3|356C / Donor, Lineage, Cell class and subclass (all cells)

ZBP1 SETD1A SLC9A1 FBXW2

1.36e-04179654f378307eb20f002450c748b7be2289d6db2fcbcb
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

EXPH5 THSD7B CADPS2 FREM1

1.36e-04179654666072c0e8448dbaec1683d18368ec2502453f90
ToppCellControl-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TMEM132C PXDNL SVEP1 FREM1

1.39e-0418065408ae0f5d95c45feba68ad99788f7af7ff4c979af
ToppCellControl-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TMEM132C PXDNL SVEP1 FREM1

1.39e-041806549b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4
ToppCellControl-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TMEM132C PXDNL SVEP1 FREM1

1.42e-041816549e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9
ToppCellSomatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

EXPH5 SLC12A7 SVEP1 RYR3

1.42e-04181654062f00736eed96e4f4327615d093558dd7d82b20
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

EXPH5 SLC12A7 SVEP1 RYR3

1.45e-04182654d3a037268f026eb2f84428b1821022503cef7756
ToppCellkidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

MRC2 LAMC3 SVEP1 NRP1

1.45e-04182654af65f0fc3f9e5d9ce69ee5faaf5b6cb7f8412e0c
ToppCellkidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

MRC2 LAMC3 SVEP1 NRP1

1.45e-04182654b7d532feb73167e05475855061b35a209583f44c
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

EML6 SPAG16 CADPS2 FREM1

1.48e-04183654b5ede5a0048c585b73c00e88aeddbcaf669347b1
ToppCellLA-11._Adipocyte|World / Chamber and Cluster_Paper

TMEM132C CSAD THSD7B ACSS2

1.48e-04183654b177be283e1553fb1f69a346f1ba79ad00297fa2
ToppCellLA-11._Adipocyte|LA / Chamber and Cluster_Paper

TMEM132C CSAD THSD7B ACSS2

1.48e-041836543f9011976782fa8aa95cdd6f00f07a91094d411b
ToppCelldroplet-Heart-4Chambers-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CSAD ECE1 SLC12A7 SHROOM2

1.48e-041836546c4a09c02e30e1f24dde39f8cb8c5b453826ee2e
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LOXHD1 SSPOP FREM1 RYR3

1.51e-04184654ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LOXHD1 SSPOP FREM1 RYR3

1.51e-041846542cbed6462fea2622871bb7e49b0df3d984239281
ToppCellSomatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

LAMC3 THSD7B SLC12A7 SVEP1

1.51e-0418465432473dbdb2de66391157c5814ef34e790806e4f2
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LOXHD1 SSPOP FREM1 RYR3

1.51e-041846542b19a8c5f823e00812908b23e66bb4e563278aff
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

EXPH5 SLC12A7 SVEP1 RYR3

1.54e-041856540b5a0df58ae2ad8261f40f152775747af4f3937a
ToppCellfacs-Skin-nan-24m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TMEM132C LAMC3 C1RL SVEP1

1.54e-041856548433a337625ff8398520e223ef92bf9bb0beb14c
ToppCellfacs-Skin-nan-24m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TMEM132C LAMC3 C1RL SVEP1

1.54e-04185654049d793d043d5d434f143025de49dd210d18756c
ToppCellfacs-Skin-nan-24m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TMEM132C LAMC3 C1RL SVEP1

1.54e-0418565463200c42565eea596f9b00728e70e544b8d50a7f
ToppCell10x3'2.3-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

TMEM132C DPYS HPX SVEP1

1.60e-04187654f1d0fc625e0e7881b3f290742fd7148d995eb71e
ToppCell10x3'2.3-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

TMEM132C DPYS HPX SVEP1

1.60e-0418765402e7246ef5ad41773d14426254e139b156d45c1d
ToppCell10x3'2.3-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

TMEM132C DPYS HPX SVEP1

1.60e-0418765408c73d125e0638c9e9878165bba2442c266c8a48
ToppCellE18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SZT2 LAMC3 SLC12A7 NRP1

1.60e-041876543699d5e71d779da922920aa3160895db187bf81b
ToppCelldroplet-Fat-SCAT-30m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SZT2 RPTN CADPS2 SHROOM2

1.60e-041876545fada3c5a58c1890029ccbfff2608b33f8cd2df7
ToppCelldroplet-Fat-SCAT-30m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SZT2 RPTN CADPS2 SHROOM2

1.60e-04187654766e808138fc2cd623c2e6d57fcb5c7378da0e03
ToppCelldroplet-Fat-SCAT-30m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SZT2 RPTN CADPS2 SHROOM2

1.60e-04187654f49d06600060deeb2fc1b1da5b93496535f20104
ToppCellFetal_29-31_weeks-Mesenchymal-pericyte_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

PXDNL KCP LAMC3 THSD7B

1.60e-04187654fa01a61bfd13feb033ba1e35cf513707b1bff8c8
ToppCellE18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SZT2 LAMC3 SLC12A7 NRP1

1.60e-04187654033ba52c0c2f9978784947098fa697368ae44834
ToppCellPCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

TMEM132C UPK1A SVEP1 FREM1

1.60e-04187654a9316e2818217ec5feae9cf8816f7249803caee6
ToppCellFetal_29-31_weeks-Mesenchymal-pericyte_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

KCP LAMC3 ECE1 SHROOM2

1.64e-04188654ccddc08121caff958a2b6f9e278a018858af6b4d
ToppCellHippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sfrp2-Inhibitory_Neuron.Gad1Gad2_Id2.Sfrp2_(Interneuron,_Neurogliaform1)|Hippocampus / BrainAtlas - Mouse McCarroll V32

UPK1A FREM1 PSD4

1.67e-0473653cc89c94a3768b02036757dea86989d9284b214b9
ToppCellHippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sfrp2|Hippocampus / BrainAtlas - Mouse McCarroll V32

UPK1A FREM1 PSD4

1.67e-04736536f28d52700bab981c8a3664ba4762f3572f7e788
ToppCellHippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sfrp2-Inhibitory_Neuron.Gad1Gad2_Id2.Sfrp2_(Interneuron,_Neurogliaform1)-|Hippocampus / BrainAtlas - Mouse McCarroll V32

UPK1A FREM1 PSD4

1.67e-0473653ae80fcf3544c18fe0318a8311e96f2448f7cb03c
ToppCellFetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

TMEM132C DPYS SVEP1 FREM1

1.67e-04189654203c80030df08ae112f9ae4043709f455d87ce89
ToppCellRA-10._Endothelium_II|World / Chamber and Cluster_Paper

TMEM132C CADPS2 ECE1 SHROOM2

1.67e-0418965475c248b9de5e2fb7a0baa8cdbab516e575cc4394
ToppCellrenal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group

PXDNL EML6 CADPS2 FREM1

1.67e-04189654830d9cd0dd706bce22eb2416f07b2c31c870a05a
ToppCell356C-Lymphocytic-CD4_T-cell-Treg_cell_3|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)

ZBP1 SETD1A SLC9A1 FBXW2

1.67e-0418965499b01893da9f9f7c9528afaffad178285211738b
ToppCellLPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TMEM132C PXDNL SVEP1 FREM1

1.67e-041896542a22b9fae70afb3dab8476f9c00e48a4df756410
DrugAC1NUSO2

GANAB SI GAA

3.28e-0611633CID005460006
DrugMDL 25,637

GLB1 SI GAA

5.66e-0613633CID000128548
Drugvaliolamine

GLB1 SI GAA

5.66e-0613633CID000174312
Drug((2-n-butyl-6,7-dichloro-2-cyclopentyl-2,3-dihydro-1-oxo-1H-inden-5-yl)oxy)acetic acid

SLC12A4 SLC12A7

7.54e-062632ctd:C095651
DrugAC1OAGYH

GLB1 SI GAA

8.97e-0615633CID006857622
DrugBeta-sistosterol [83-46-5]; Down 200; 9.6uM; PC3; HT_HG-U133A

DPYS BCL2L2 CPT1B ECE1 CA5B EML3

1.65e-051956364073_DN
DrugCarteolol hydrochloride [51781-21-6]; Down 200; 12.2uM; PC3; HT_HG-U133A

DPYS IDS ECE1 EML3 SVEP1 PSD4

1.75e-051976364096_DN
DrugNSC624987

GLB1 SI GAA

2.99e-0522633CID000001472
Drugemiglitate

GLB1 SI GAA

2.99e-0522633CID000072004
Drugindolizidine

GLB1 PUM2 GAA

4.45e-0525633CID000026136
DrugAcarbose

SI GAA

4.51e-054632DB00284
Diseaseorofacial cleft (is_implicated_in)

LOXHD1 ACSS2

9.66e-057642DOID:0050567 (is_implicated_in)
Diseaseneuritic plaque measurement

TMEM132C PXDNL LAMC3 SVEP1 FREM1 RYR3

1.10e-04349646EFO_0006798
Diseaseglycerate measurement

THSD7B RYR3

4.77e-0415642EFO_0021029
Diseasemean arterial pressure

SLC9A1 SZT2 PXDNL EML6 THSD7B SVEP1

7.42e-04499646EFO_0006340
DiseaseAutism Spectrum Disorders

LAMC3 NSUN2 RAI1

8.47e-0485643C1510586
Diseasealcohol use disorder (implicated_via_orthology)

ARID2 ACSS2 RYR3 PSD4

8.62e-04195644DOID:1574 (implicated_via_orthology)
DiseaseHypertrophic obstructive cardiomyopathy

SLC9A1 GAA

1.35e-0325642C4551472
DiseaseBone Diseases, Developmental

GLB1 IFT80

1.57e-0327642C0005941
Diseaseinterleukin 5 measurement

SPAG16 ECE1

1.69e-0328642EFO_0008185

Protein segments in the cluster

PeptideGeneStartEntry
LKQFHFHWGAIDAWG

CA5B

126

Q9Y2D0
FHWGAIDAWGSEHTV

CA5B

131

Q9Y2D0
ESSAHWPIFKWSHDG

EIF3B

421

P55884
SHEGTSGEWIWESLF

ARID2

256

Q68CP9
DWIHSSGGWAEFTAL

BCL2L2

136

Q92843
DVFWCTADIGWITGH

ACSS2

351

Q9NR19
HLFTCSEDGSLWHWD

NUP43

276

Q8NFH3
EHWVHEACAVWTGGV

RAI1

1821

Q7Z5J4
GDDEWRETAWGASHH

PUM2

41

Q8TB72
GQWFTDWDAVPHSRH

NSUN2

371

Q08J23
HWDHAVFVARGALWG

ASPDH

116

A6ND91
SLGTDGTHYWNKEWH

DPYS

276

Q14117
VWHDKRSSGSGWHLE

LOXHD1

491

Q8IVV2
GWGHRDSGHHDEAWA

GLB1

526

P16278
GVGHDPAKEFTNHWW

GPATCH4

51

Q5T3I0
HSHGTNWVEYNVTGW

MYO18A

931

Q92614
FWIGLNDQVHAGHWE

FREM1

2111

Q5H8C1
HWWIGLHTSESDGRF

MRC2

886

Q9UBG0
WGQEKGHSFWSDFHR

EXPH5

481

Q8NEV8
EFGWGSHKTFCHWEH

NRP1

651

O14786
WGWFLEHDLDHTVPA

PXDNL

806

A1KZ92
ANHSWAHSEGSGWLG

CD1E

46

P15812
GHVVFAHVVEQHWEW

IFT80

291

Q9P2H3
VVWDNHAHHWVATGI

C1RL

441

Q9NZP8
HAHHWVATGIVSWGI

C1RL

446

Q9NZP8
EHHAEGREAFAWWPD

CADPS2

856

Q86UW7
HGLWLHVDAAWGGSV

CSAD

266

Q9Y600
HGRYAGHWTGDVWSS

GAA

606

P10253
KSHVHFWNWSGGVGV

EML3

426

Q32P44
WSHDFQWVLSTGGAD

EML6

571

Q6ZMW3
DGHSRWGTFSNLWEH

ECE1

141

P42892
FTSDHGWALGEHGEW

IDS

331

P22304
WEWSSGARTQHFRGH

FBXW2

211

Q9UKT8
FGGGHIDVWWIVHDG

SLC12A7

841

Q9Y666
AEHAWADAPIIGHLW

CPT1B

471

Q92523
GHWHDFAHLELQGSW

MROH5

956

Q6ZUA9
LHGKSGTWWDEHLSE

MRPL3

41

P09001
DTSRDGWHSWPIAHQ

HPX

286

P02790
GTWDSAHVHVLFHLW

RTP5

61

Q14D33
HGEPSSAAWAWHSHE

SZT2

1791

Q5T011
SAAWAWHSHEDRAEG

SZT2

1796

Q5T011
HWASWAHICGGSLIH

PRSS29P

91

A6NIE9
WTPLHAAAHWGVEDA

PPP1R12C

261

Q9BZL4
QGWHAGGDAYAKWHT

SSPOP

2106

A2VEC9
THSHDWVWLGNEAEL

TMEM132C

966

Q8N3T6
TEGGSHWEHGQEWTT

KCP

256

Q6ZWJ8
FGAVWTGDNTAEWDH

GANAB

611

Q14697
WGSGVELTHLGSWVH

PSD4

66

Q8NDX1
GWRPHSWHATKFSDS

SHROOM2

111

Q13796
RHAAHWLGDNTASWE

SI

596

P14410
NDGRWHHIAITWTSA

SVEP1

1506

Q4LDE5
GADWLNDTHWVHHTI

SETD1A

1456

O15047
HERASSDWWRGEHNG

ARHGAP4

776

P98171
YLEGHIDVWWIVHDG

SLC12A4

841

Q9UP95
FDWSGTGRADAHSLW

ULBP3

21

Q9BZM4
RHHWEVEVGSKDGWA

TRIM7

396

Q9C029
VATLWDGHAAVWHGY

TMEM68

96

Q96MH6
GSHYVDEASHEGSWW

ZBP1

411

Q9H171
HSEGVNWEPWKGHEF

TNN

1251

Q9UQP3
EHATGEACWWTIHPA

RYR3

141

Q15413
KGGAQHTWGFHTWLD

TEX52

86

A6NCN8
TFEGHSRAVWSCTWH

SPAG16

431

Q8N0X2
STVAGSHHWNWTFVI

SLC9A1

401

P19634
HIGHAIDSYTWGISW

UPK1A

221

O00322
VWCFHVDGWTSHLSN

THSD7B

66

Q9C0I4
LSHWAEEEQGHQTWD

RPTN

701

Q6XPR3
LSDFHQGAEGWWARS

LAMC3

501

Q9Y6N6
RQGHSHSADWWSYGV

RPS6KA1

236

Q15418